Vaxart Jumps 12% On Positive Data From Oral Covid-19 Vaccine Study

(RTTNews) - Shares of Vaxart Inc. (VXRT) jumped over 12% in extended hours on Thursday driven by positive results form oral Covid-19 vaccine.

A Duke University-led study published in bioRxiv confirmed previous findings that Vaxart's investigational oral tablet vaccine reduced the airborne transmission of SARS-CoV-2 virus more than injectable vaccines.

Study suggests mucosal vaccines may protect not only vaccinated, but also unvaccinated animals.

These results are consistent with those from Vaxart's Phase II human flu challenge study, which showed that Vaxart's oral tablet vaccine was better at reducing shedding than the injectable flu vaccine.

Vaxart said that the limitation of the currently approved injected COVID-19 vaccines is that airborne transmission occurs in people who have received them.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Октябрь 2021    »